Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-001825
Filing Date
2024-01-05
Accepted
2024-01-05 16:31:07
Documents
1
Period of Report
2024-01-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm242141-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm242141-2_4seq1.xml 4 3485
  Complete submission text file 0001104659-24-001825.txt   4925
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Issuer) CIK: 0001875558 (see all company filings)

EIN.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NUVECTIS PHARMA, INC. 1 BRIDGE PLAZA FORT LEE NJ 07024
Business Address
Poradosu Enrique (Reporting) CIK: 0001898147 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41264 | Film No.: 24516682